NL-OMON46270
Completed
Not Applicable
Continuous measurements of vital signs, activity variables and exposure to air pollution in patients with COPD - Continuous measurements in COPD
Vlaamse Instelling voor Technologisch Onderzoek0 sites29 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Vlaamse Instelling voor Technologisch Onderzoek
- Enrollment
- 29
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Trial is onging in other countries
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- COPD as a primary diagnosis, diagnosed by a chest physician
- •\- Clinically stable
- •\- Treated according to the current international guidelines
- •\- Permission for voluntary participation
Exclusion Criteria
- •\- Lack of motivation for voluntary participation in this study
- •\- Receiving oxygen therapy
- •\- Making use of a rollator to assist walking
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
on-Invasive rapid assessment of patients with liver transplants using Magnetic Resonance Imaging with LiverMultiScaNL-OMON45260Perspectum Diagnostics56
Completed
Not Applicable
PRostate Evaluation for Clinically Important disease: Sampling using Image-guidance Or Not?Prostaatkanker detectieprostatecancerNL-OMON42747Radboud Universitair Medisch Centrum17
Completed
Phase 4
An Open-Label Study of the Safety and Efficacy of ReFacto AF in Previously Untreated Patients in Usual Care Settingsfactor VIII deficiencyHemophilia A1006447710005330NL-OMON39506Pfizer1
Completed
Not Applicable
Clinical Study to Evaluate the Safety and Performance of MANTA Vascular Closure DeviceAandoeningen aan de hartklepCardiac diseaseVascular intervention1001928010003184NL-OMON42594Essential Medical Inc.35
Completed
Phase 2
Prospective evaluation of the predictive value of a circulating tumor cell (CTC) sensitivity profile to Cisplatin chemotherapy in metastatic breast cancer patientsMetastatic breast cancermetastatic mammary cancer10006291NL-OMON44123Erasmus MC, Universitair Medisch Centrum Rotterdam67